RLMD
Relmada Therapeutics Inc

1,931
Mkt Cap
$324.13M
Volume
1.65M
52W High
$5.12
52W Low
$0.2404
PE Ratio
-2.46
RLMD Fundamentals
Price
$4.31
Prev Close
$4.42
Open
$4.50
50D MA
$3.06
Beta
0.54
Avg. Volume
2.28M
EPS (Annual)
-$2.65
P/B
15.50
Rev/Employee
$0.00
Loading...
Loading...
Latest Earnings Results: Q3 '25
Reported: Nov 13

Estimated EPS

-$0.42

Reported EPS

-$0.30

Surprise

+29.28%

Estimated Rev

$0M

Reported Rev

$0M

Surprise

+100%

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '25
-$0.17
--
--
N/A
Q3 '25
-$0.42
-$0.30
29.28%
BEAT
Q2 '25
-$0.46
-$0.30
34.78%
BEAT
Q1 '25
-$0.48
-$0.58
-20.83%
MISSED
Q4 '24
-$0.71
-$0.62
12.26%
BEAT

Latest RLMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.